Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients

Adjuvant chemotherapy has been established as standard treatment for advanced cancer among multidisciplinary therapies. A simple and instructive biomarker for therapeutic response and recurrence is needed to evaluate the therapeutic effect. Jab1/COPS5 level has been shown to be associated with tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Junna, Liu, Guohong, Yuan, Yufen, Wang, Dong, Jiao, Pengfei, Xing, Lihua, Pan, Yunbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722579/
https://www.ncbi.nlm.nih.gov/pubmed/29228627
http://dx.doi.org/10.18632/oncotarget.22146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722579/
https://www.ncbi.nlm.nih.gov/pubmed/29228627
http://dx.doi.org/10.18632/oncotarget.22146

Ejemplares similares